Remdesivir was created and developed by Gilead Sciences as a treatment for Ebola virus and Marburg viral infections. Gilead Sciences then discovered that remdesivir had in vitro antiviral activity against several filoviruses, pneumoviruses, paramyxoviruses and coronaviruses.
Remdesivir iliundwa na kukuzwa na Gilead Sciences kama matibabu ya ugonjwa wa virusi vya Ebola na maambukizo ya virusi vya Marburg . Gilead Sciences baadaye iligundua kuwa Remdesivir ilikuwa na shughuli ya kuzuia virusi katika vitro dhidi ya filo-, pneumo-, paramyxo-, na virusi vya korona.